413 related articles for article (PubMed ID: 16192632)
1. Secretin receptors in normal and diseased human pancreas: marked reduction of receptor binding in ductal neoplasia.
Körner M; Hayes GM; Rehmann R; Zimmermann A; Friess H; Miller LJ; Reubi JC
Am J Pathol; 2005 Oct; 167(4):959-68. PubMed ID: 16192632
[TBL] [Abstract][Full Text] [Related]
2. Silencing of secretin receptor function by dimerization with a misspliced variant secretin receptor in ductal pancreatic adenocarcinoma.
Ding WQ; Cheng ZJ; McElhiney J; Kuntz SM; Miller LJ
Cancer Res; 2002 Sep; 62(18):5223-9. PubMed ID: 12234988
[TBL] [Abstract][Full Text] [Related]
3. Vasoactive intestinal peptide (VIP) stimulates in vitro growth of VIP-1 receptor-bearing human pancreatic adenocarcinoma-derived cells.
Jiang S; Kopras E; McMichael M; Bell RH; Ulrich CD
Cancer Res; 1997 Apr; 57(8):1475-80. PubMed ID: 9108448
[TBL] [Abstract][Full Text] [Related]
4. Ductal neoplasia of the pancreas: nosologic, clinicopathologic, and biologic aspects.
Adsay NV; Basturk O; Cheng JD; Andea AA
Semin Radiat Oncol; 2005 Oct; 15(4):254-64. PubMed ID: 16183479
[TBL] [Abstract][Full Text] [Related]
5. Distinct expression patterns of claudin-1 and claudin-4 in intraductal papillary-mucinous tumors of the pancreas.
Tsukahara M; Nagai H; Kamiakito T; Kawata H; Takayashiki N; Saito K; Tanaka A
Pathol Int; 2005 Feb; 55(2):63-9. PubMed ID: 15693851
[TBL] [Abstract][Full Text] [Related]
6. Where and when does pancreatic carcinoma start?
Lüttges J; Hahn S; Klöppel G
Med Klin (Munich); 2004 Apr; 99(4):191-5. PubMed ID: 15085289
[TBL] [Abstract][Full Text] [Related]
7. Serine protease inhibitor Kazal type 1 and epidermal growth factor receptor are expressed in pancreatic tubular adenocarcinoma, intraductal papillary mucinous neoplasm, and pancreatic intraepithelial neoplasia.
Ozaki N; Ohmuraya M; Ida S; Hashimoto D; Ikuta Y; Chikamoto A; Hirota M; Baba H
J Hepatobiliary Pancreat Sci; 2013 Aug; 20(6):620-7. PubMed ID: 23475261
[TBL] [Abstract][Full Text] [Related]
8. The dichotomy in the preinvasive neoplasia to invasive carcinoma sequence in the pancreas: differential expression of MUC1 and MUC2 supports the existence of two separate pathways of carcinogenesis.
Adsay NV; Merati K; Andea A; Sarkar F; Hruban RH; Wilentz RE; Goggins M; Iocobuzio-Donahue C; Longnecker DS; Klimstra DS
Mod Pathol; 2002 Oct; 15(10):1087-95. PubMed ID: 12379756
[TBL] [Abstract][Full Text] [Related]
9. p53 protein expression in intraductal papillary mucinous tumors (IPMT) of the pancreas as an indicator of tumor malignancy.
Kawahira H; Kobayashi S; Kaneko K; Asano T; Ochiai T
Hepatogastroenterology; 2000; 47(34):973-7. PubMed ID: 11020860
[TBL] [Abstract][Full Text] [Related]
10. Pancreatic tumors with cystic dilatation of the ducts: intraductal papillary mucinous neoplasms and intraductal oncocytic papillary neoplasms.
Adsay NV; Longnecker DS; Klimstra DS
Semin Diagn Pathol; 2000 Feb; 17(1):16-30. PubMed ID: 10721804
[TBL] [Abstract][Full Text] [Related]
11. Histologic characteristics of pancreatic intraepithelial neoplasia associated with different pancreatic lesions.
Recavarren C; Labow DM; Liang J; Zhang L; Wong M; Zhu H; Wang J; Francis F; Xu R
Hum Pathol; 2011 Jan; 42(1):18-24. PubMed ID: 21056895
[TBL] [Abstract][Full Text] [Related]
12. [Pathologic characteristics and evaluation of the pancreatic cancer].
Fukushima N; Mukai K
Gan To Kagaku Ryoho; 2005 May; 32(5):599-604. PubMed ID: 15918557
[TBL] [Abstract][Full Text] [Related]
13. Molecular genetics of intraductal papillary-mucinous neoplasms of the pancreas.
Furukawa T
J Hepatobiliary Pancreat Surg; 2007; 14(3):233-7. PubMed ID: 17520197
[TBL] [Abstract][Full Text] [Related]
14. Molecular cloning and functional characterization of a human secretin receptor.
Chow BK
Biochem Biophys Res Commun; 1995 Jul; 212(1):204-11. PubMed ID: 7612008
[TBL] [Abstract][Full Text] [Related]
15. Progressive genomic alterations in intraductal papillary mucinous tumours of the pancreas and morphologically similar lesions of the pancreatic ducts.
Soldini D; Gugger M; Burckhardt E; Kappeler A; Laissue JA; Mazzucchelli L
J Pathol; 2003 Apr; 199(4):453-61. PubMed ID: 12635136
[TBL] [Abstract][Full Text] [Related]
16. In vitro modeling of human pancreatic duct epithelial cell transformation defines gene expression changes induced by K-ras oncogenic activation in pancreatic carcinogenesis.
Qian J; Niu J; Li M; Chiao PJ; Tsao MS
Cancer Res; 2005 Jun; 65(12):5045-53. PubMed ID: 15958547
[TBL] [Abstract][Full Text] [Related]
17. MUC4 expression increases progressively in pancreatic intraepithelial neoplasia.
Swartz MJ; Batra SK; Varshney GC; Hollingsworth MA; Yeo CJ; Cameron JL; Wilentz RE; Hruban RH; Argani P
Am J Clin Pathol; 2002 May; 117(5):791-6. PubMed ID: 12090430
[TBL] [Abstract][Full Text] [Related]
18. Pdcd4 expression in intraductal papillary mucinous neoplasm of the pancreas: its association with tumor progression and proliferation.
Hayashi A; Aishima S; Miyasaka Y; Nakata K; Morimatsu K; Oda Y; Nagai E; Oda Y; Tanaka M; Tsuneyoshi M
Hum Pathol; 2010 Nov; 41(11):1507-15. PubMed ID: 20656320
[TBL] [Abstract][Full Text] [Related]
19. Analysis of c-kit protein expression in pancreatic neoplasms and its implication for prognosis.
Kimura W; Ma J; Takeshita A; Yamamoto T; Moriya T; Hirai I; Fuse A
Hepatogastroenterology; 2007 Dec; 54(80):2203-8. PubMed ID: 18265633
[TBL] [Abstract][Full Text] [Related]
20. Observations on the etiology and pathogenesis of intraductal papillary-mucinous neoplasms of the pancreas.
Longnecker DS
Hepatogastroenterology; 1998; 45(24):1973-80. PubMed ID: 9951850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
